{
    "clinical_study": {
        "@rank": "79034", 
        "acronym": "HEPHYGI", 
        "arm_group": [
            {
                "arm_group_label": "controls persons", 
                "arm_group_type": "Other", 
                "description": "controls persons"
            }, 
            {
                "arm_group_label": "GS patients", 
                "arm_group_type": "Other", 
                "description": "GS patients"
            }, 
            {
                "arm_group_label": "heterozygous carriers", 
                "arm_group_type": "Other", 
                "description": "heterozygous carriers"
            }
        ], 
        "brief_summary": {
            "textblock": "Gitelman syndrome is a salt wasting tubulopathy caused by mutations in the SLC12A3 gene\n      coding for the thiazide sensitive sodium chloride cotransporter. This disease mimics the\n      chronic treatment with thiazide diuretics and is characterized by renal hypokalemia, low to\n      normal blood pressure, hypocalciuria and hypomagnesemia. The purpose of this study is to\n      determine whether the heterozygous carriers present the metabolic risks and/or the benefits\n      of this disease."
        }, 
        "brief_title": "Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter", 
        "completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Heterozygous Carriers of Gitelman Syndrome", 
        "condition_browse": {
            "mesh_term": "Gitelman Syndrome"
        }, 
        "detailed_description": {
            "textblock": "Gitelman syndrome (GS), is an autosomal recessive salt wasting tubulopathy caused mainly by\n      loss of function mutations in the SLC12A3 gene coding for the thiazide sensitive\n      sodium-chloride cotransporter (NCC). Thus, GS mimics a chronic treatment with high doses of\n      thiazide diuretics. NCC is expressed in the distal convoluted tubule, which is responsible\n      for 7% of sodium chloride reabsorption.  GS is the more frequent hereditary tubulopathy with\n      estimated prevalence of 1/40000, which implicates that 1% of general population are\n      heterozygous carriers (600 000 in France). Previous publications suggest that the apparently\n      asymptomatic heterozygous carriers could present some clinical traits of GS or chronic\n      thiazide treatment. These including: beneficial aspects (low blood pressure, low urinary\n      calcium excretions) or metabolic risks (hypokalemia, insulin resistance). Nevertheless,\n      these studies do not evaluate all the aspects and blood pressure was evaluated once in\n      hospital setting.   This study aims to compare home monitoring blood pressure; salt balance;\n      potassium, glucose lipid and mineral metabolism and vascular function in 100 heterozygous\n      carriers, 50 GS patients and 100 controls persons (without mutations in SLC12A3 gene)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Gitelman syndrome patients, relatives carrying heterozygous mutations and relatives\n             or healthy voluntaries without mutations."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02035046", 
            "org_study_id": "P120111"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "controls persons", 
                    "GS patients", 
                    "heterozygous carriers"
                ], 
                "intervention_name": "Blood sample", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "controls persons", 
                    "GS patients", 
                    "heterozygous carriers"
                ], 
                "intervention_name": "Urine sample", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "controls persons", 
                    "GS patients", 
                    "heterozygous carriers"
                ], 
                "intervention_name": "Blood pressure", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Gitelman", 
            "Heterozygous SLC12A3 mutation", 
            "Blood pressure", 
            "Hypokalemia"
        ], 
        "lastchanged_date": "January 10, 2014", 
        "location": [
            {
                "contact": {
                    "email": "marie.essig@inserm.fr", 
                    "last_name": "Marie Essig, MD, PhD", 
                    "phone": "+33 (0)5 55 05 64 51"
                }, 
                "contact_backup": {
                    "email": "Julien.Allard@chu-limoges.fr", 
                    "last_name": "Julien Allard, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "zip": "87042 Limoges cedex"
                    }, 
                    "name": "Nephrology Department. Centre Hospitalier Universitaire, H\u00f4pital Dupuytren"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "laurence.dubourg@chu-lyon.fr", 
                    "last_name": "Laurence Dubourg, MD, PhD", 
                    "phone": "+33 (0)4 72 11 02 44"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69437 Lyon"
                    }, 
                    "name": "Department of Functional Investigations. Hospices Civils de Lyon, H\u00f4pital Edouard Herriot."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "anne.balanchard@egp.aphp.fr", 
                    "last_name": "Anne Blanchard, MD, PhD", 
                    "phone": "+33 (0)1 56 09 29 13"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75908"
                    }, 
                    "name": "Clinical Research Center. Assistance Publique H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jean-philippe.haymann@tnn.aphp.fr", 
                    "last_name": "Jean Philippe Haymann, MD, PhD", 
                    "phone": "+33 (0)1 56 01 67 74"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75020"
                    }, 
                    "name": "Department of Functional Investigations. Assistance Publique H\u00f4pitaux de Paris, H\u00f4pital Tenon"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "tack.i@chu-toulouse.fr", 
                    "last_name": "Ivan Tack, MD, PhD", 
                    "phone": "+ 33 (0)5 61 32 26 83"
                }, 
                "contact_backup": {
                    "email": "vallet.m@chu-toulouse.fr", 
                    "last_name": "Marion Vallet, MD, PhD", 
                    "phone": "+ 33 (0)5 61 32 26 83"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31059 TOULOUSE cedex 9"
                    }, 
                    "name": "Department of Functional Investigations. Centre Hospitalier Universitaire, H\u00f4pital de Rangueil."
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "3", 
        "official_title": "Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter", 
        "overall_official": [
            {
                "affiliation": "Departement of Genetics. Assistance Publique H\u00f4pitaux de Paris,H\u00f4pital Europ\u00e9en Georges Pompidou.", 
                "last_name": "Rosa Vargas-Poussou, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Clinical Research Center. Assistance Publique H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou. Paris, France", 
                "last_name": "Anne Blanchard, MD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Departement of Nephrology. Centre Hospitalier Universitaire. Limoges, France", 
                "last_name": "Marie Essig, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Department of Functional Investigations. Assistance Publique H\u00f4pitaux de Paris, H\u00f4pital Tenon, Paris, France", 
                "last_name": "Jean Philippe Haymann, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Department of Functional Investigations. Centre Hospitalier Universitaire, H\u00f4pital de Rangueil. Toulouse, France", 
                "last_name": "Ivan Tack, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Department of Functional Investigations. Hospices Civils de Lyon, H\u00f4pital Edouard Herriot. Lyon, France", 
                "last_name": "Laurence DUBOURG, MD, PhD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "self-measurement at home, 3 times a day during 3 consecutive days", 
            "measure": "Systolic blood pressure evaluated by self-measurement", 
            "safety_issue": "No", 
            "time_frame": "3 days"
        }, 
        "reference": [
            {
                "PMID": "11408395", 
                "citation": "Cruz DN, Simon DB, Nelson-Williams C, Farhi A, Finberg K, Burleson L, Gill JR, Lifton RP. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension. 2001 Jun;37(6):1458-64."
            }, 
            {
                "PMID": "15198479", 
                "citation": "Tago N, Kokubo Y, Inamoto N, Naraba H, Tomoike H, Iwai N. A high prevalence of Gitelman's syndrome mutations in Japanese. Hypertens Res. 2004 May;27(5):327-31."
            }, 
            {
                "PMID": "17981812", 
                "citation": "Fava C, Montagnana M, Rosberg L, Burri P, Almgren P, J\u00f6nsson A, Wanby P, Lippi G, Minuz P, Hulth\u00e8n LU, Aurell M, Melander O. Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure. Hum Mol Genet. 2008 Feb 1;17(3):413-8. Epub 2007 Nov 1."
            }, 
            {
                "PMID": "18391953", 
                "citation": "Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, Newton-Cheh C, State MW, Levy D, Lifton RP. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008 May;40(5):592-9. doi: 10.1038/ng.118. Epub 2008 Apr 6."
            }, 
            {
                "PMID": "19033254", 
                "citation": "Hsu YJ, Yang SS, Chu NF, Sytwu HK, Cheng CJ, Lin SH. Heterozygous mutations of the sodium chloride cotransporter in Chinese children: prevalence and association with blood pressure. Nephrol Dial Transplant. 2009 Apr;24(4):1170-5. doi: 10.1093/ndt/gfn619. Epub 2008 Nov 25."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02035046"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Blood renin and aldosterone measurements, 24h urinary sodium and aldosterone excretion", 
                "measure": "Salt balance", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Dietary intake, blood potassium and 24 h urinary potassium excretion", 
                "measure": "Potassium metabolism", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "BMI, blood cholesterol, LDL, HDL and triglycerides.", 
                "measure": "Lipide metabolism", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "measure": "Glucose, insulin, HOMA index, pre and post test", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Blood and urinary calcium, magnesium and phosphate. PTH, 25 OH vitamin D calcitriol, bone remodeling markers", 
                "measure": "Mineral metabolism", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Estimated GFR, proteinuria and albuminuria", 
                "measure": "Renal function", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Pulse wave velocity and central blood pressure. Blood and urinary vascular function markers", 
                "measure": "Vascular function evaluation", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "collaborator": {
                "agency": "Ministry of Health, France", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}